Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03244176
Title Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study (AvR-CHOP)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Austin Health
Indications

diffuse large B-cell lymphoma

Therapies

Avelumab

Age Groups: adult | senior
Covered Countries


No variant requirements are available.